Most of the patients (n = 94) were initially checked for C9orf72 hexanucleotide repeat expansions at the Neurogenetics Laboratory of Eginition Hospital according to a two-step protocol. This protocol included sizing PCR (amplification of the region that contains the hexanucleotide repeat with primers flanking this region), agarose electrophoresis and fragment analysis to identify samples with possible presence of the C9orf72 repeat expansion. This was followed by repeat primed PCR, to verify and separate samples with the C9orf72 repeat expansion, as previously described [21 (link),22 (link)]. Samples were then electrophorized on an ABI 310 Capillary Analyzer (Applied Biosystems, Foster City, CA, USA) and analyzed on GeneScan v3.7 (2001, Applied Biosystems, Foster City, CA, USA). In addition, 21 patients were initially analyzed for the presence of C9orf72 repeat expansion by repeat primed PCR amplification and STR (short tandem repeats) PCR analysis at the Diagnostic Service Facility, Laboratory of Neurogenetics, University of Antwerp, Belgium.
Free full text: Click here